The mortality rate of people with cancer judged to have a limited life expectancy by physicians performing work disability assessments in the Netherlands: a retrospective cohort study

荷兰医生进行工作能力评估后判定预期寿命有限的癌症患者的死亡率:一项回顾性队列研究

阅读:1

Abstract

PURPOSE: There is a lack of consensus among physicians working in the field of disability assessment about the definition of a limited life expectancy. The aim of this study was to describe the mortality rate of employees with cancer who were judged to have a limited life expectancy and to study whether factors are associated with mortality. METHODS: A retrospective cohort study, including 534 Dutch employees with a diagnosis of cancer who were granted full work disability pension after being judged by physicians working in the field of disability assessment as having a limited life expectancy. Descriptive statistics were used to describe the one- and two-year mortality rates. Factors potentially associated with mortality were studied using univariate logistic regression analysis. RESULTS: The mortality rates one and two years after the disability assessment were 46% (n = 247) and 63% (n = 339), respectively. We did not observe a statistically significant association between age at death or between sex and death after one year, but after two years the probability of death was greater among men. Both one and two-years after the disability assessment, the probability of dying was greater among employees diagnosed with a digestive type of cancer, compared to employees diagnosed with a urogenital type of cancer. CONCLUSIONS: Approximately six in ten people died within two years of their work disability assessment. In addition to the type of cancer, no factors in this study were associated with mortality. Physicians should be supported in making evidence-based assessments of life expectancy in patients with cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。